341 related articles for article (PubMed ID: 32562612)
21. Racial and Ethnic Disparities in Lung Cancer Screening Eligibility.
Narayan AK; Chowdhry DN; Fintelmann FJ; Little BP; Shepard JO; Flores EJ
Radiology; 2021 Dec; 301(3):712-720. PubMed ID: 34546133
[TBL] [Abstract][Full Text] [Related]
22. Skin biopsy and skin cancer treatment use in the Medicare population, 1993 to 2016.
Skaggs R; Coldiron B
J Am Acad Dermatol; 2021 Jan; 84(1):53-59. PubMed ID: 32553682
[TBL] [Abstract][Full Text] [Related]
23. Variations in cataract extraction rates in Medicare prepaid and fee-for-service settings.
Goldzweig CL; Mittman BS; Carter GM; Donyo T; Brook RH; Lee P; Mangione CM
JAMA; 1997 Jun; 277(22):1765-8. PubMed ID: 9178788
[TBL] [Abstract][Full Text] [Related]
24. Factors Associated With Declining Lung Cancer Screening After Discussion With a Physician in a Cohort of US Veterans.
Núñez ER; Caverly TJ; Zhang S; Glickman ME; Qian SX; Boudreau JH; Miller DR; Slatore CG; Wiener RS
JAMA Netw Open; 2022 Aug; 5(8):e2227126. PubMed ID: 35972738
[TBL] [Abstract][Full Text] [Related]
25. Comparison of performance of traditional Medicare vs Medicare managed care.
Landon BE; Zaslavsky AM; Bernard SL; Cioffi MJ; Cleary PD
JAMA; 2004 Apr; 291(14):1744-52. PubMed ID: 15082702
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Lung Cancer Screening Eligibility and Use between Commercial, Medicare, and Medicare Advantage Enrollees.
Hughes DR; Chen J; Wallace AE; Rajendra S; Santavicca S; Duszak R; Rula EY; Smith RA
J Am Coll Radiol; 2023 Apr; 20(4):402-410. PubMed ID: 37001939
[TBL] [Abstract][Full Text] [Related]
27. Comparing post-acute rehabilitation use, length of stay, and outcomes experienced by Medicare fee-for-service and Medicare Advantage beneficiaries with hip fracture in the United States: A secondary analysis of administrative data.
Kumar A; Rahman M; Trivedi AN; Resnik L; Gozalo P; Mor V
PLoS Med; 2018 Jun; 15(6):e1002592. PubMed ID: 29944655
[TBL] [Abstract][Full Text] [Related]
28. Shared Decision-Making for Lung Cancer Screening: How Well Are We "Sharing"?
Nishi SPE; Lowenstein LM; Mendoza TR; Lopez Olivo MA; Crocker LC; Sepucha K; Niu J; Volk RJ
Chest; 2021 Jul; 160(1):330-340. PubMed ID: 33556362
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Revised US Preventive Services Task Force Lung Cancer Screening Guideline Among Women and Racial/Ethnic Minority Populations.
Reese TJ; Schlechter CR; Potter LN; Kawamoto K; Del Fiol G; Lam CY; Wetter DW
JAMA Netw Open; 2021 Jan; 4(1):e2033769. PubMed ID: 33433600
[TBL] [Abstract][Full Text] [Related]
30. Racial Disparities in Lung Cancer Screening: An Exploratory Investigation.
Japuntich SJ; Krieger NH; Salvas AL; Carey MP
J Natl Med Assoc; 2018 Oct; 110(5):424-427. PubMed ID: 30129479
[TBL] [Abstract][Full Text] [Related]
31. Lung Cancer Screening in Brazil Comparing the 2013 and 2021 USPSTF Guidelines.
Emmerick ICM; Campos MR; Castanheira D; Muzy J; Marques A; Arueira Chaves L; Sobreira da Silva MJ
JAMA Netw Open; 2023 Dec; 6(12):e2346994. PubMed ID: 38079172
[TBL] [Abstract][Full Text] [Related]
32. Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.
Liu Y; Pan IE; Tak HJ; Vlahos I; Volk R; Shih YT
JAMA Netw Open; 2022 Nov; 5(11):e2243163. PubMed ID: 36409492
[TBL] [Abstract][Full Text] [Related]
33. Association of the Overall Well-being of a Population With Health Care Spending for People 65 Years of Age or Older.
Riley C; Roy B; Herrin J; Spatz ES; Arora A; Kell KP; Rula EY; Krumholz HM
JAMA Netw Open; 2018 Sep; 1(5):e182136. PubMed ID: 30646154
[TBL] [Abstract][Full Text] [Related]
34. Use of preventive services by Medicare fee-for-service beneficiaries: does spillover from managed care matter?
Koroukian SM; Litaker D; Dor A; Cooper GS
Med Care; 2005 May; 43(5):445-52. PubMed ID: 15838408
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.
Ritzwoller DP; Meza R; Carroll NM; Blum-Barnett E; Burnett-Hartman AN; Greenlee RT; Honda SA; Neslund-Dudas C; Rendle KA; Vachani A
JAMA Netw Open; 2021 Oct; 4(10):e2128176. PubMed ID: 34636916
[TBL] [Abstract][Full Text] [Related]
36. Accelerating integration of tobacco use treatment in the context of lung cancer screening: Relevance and application of implementation science to achieving policy and practice.
Shelley D; Wang VH; Taylor K; Williams R; Toll B; Rojewski A; Foley KL; Rigotti N; Ostroff JS
Transl Behav Med; 2022 Nov; 12(11):1076-1083. PubMed ID: 36227937
[TBL] [Abstract][Full Text] [Related]
37. Racial-Ethnic Composition of Primary Care Practices and Comprehensive Primary Care Plus Initiative Participation.
Rubio K; Fraze TK; Bibi S; Rodriguez HP
J Gen Intern Med; 2023 Oct; 38(13):2945-2952. PubMed ID: 36941423
[TBL] [Abstract][Full Text] [Related]
38. Regional Variation of Computed Tomographic Imaging in the United States and the Risk of Nephrectomy.
Welch HG; Skinner JS; Schroeck FR; Zhou W; Black WC
JAMA Intern Med; 2018 Feb; 178(2):221-227. PubMed ID: 29279887
[TBL] [Abstract][Full Text] [Related]
39. Differences in Management of Coronary Artery Disease in Patients With Medicare Advantage vs Traditional Fee-for-Service Medicare Among Cardiology Practices.
Figueroa JF; Blumenthal DM; Feyman Y; Frakt AB; Turchin A; Doros G; Gao Q; Song Y; Joynt Maddox KE
JAMA Cardiol; 2019 Mar; 4(3):265-271. PubMed ID: 30785590
[TBL] [Abstract][Full Text] [Related]
40. Patient-Provider Lung Cancer Screening Discussions: An Analysis of a National Survey.
Nourmohammadi N; Liang THP; Sadigh G
Clin Lung Cancer; 2024 Jun; 25(4):e189-e195.e2. PubMed ID: 38522980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
